Sylvie Klieber

929 total citations
18 papers, 436 citations indexed

About

Sylvie Klieber is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Sylvie Klieber has authored 18 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 6 papers in Oncology and 4 papers in Hepatology. Recurrent topics in Sylvie Klieber's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Sylvie Klieber is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Sylvie Klieber collaborates with scholars based in France, United States and Italy. Sylvie Klieber's co-authors include Sabine Gerbal‐Chaloin, Patrick Maurel, Martine Daujat‐Chavanieu, Gérard Fabre, Cédric Duret, Bertrand Suc, António Sá Cunha, Arti Ahluwalia, Xavier Boulenc and Bruna Vinci and has published in prestigious journals such as The FASEB Journal, Molecular Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

Sylvie Klieber

18 papers receiving 423 citations

Peers

Sylvie Klieber
Malin Darnell Sweden
María José Gómez Lechón Spain
Kaori Nakamoto United States
Frederic Moulin United States
Chitra Kanchagar United States
Isabel Conde Spain
J. E. Dinger Germany
Akiko Koeda Japan
Janneke Keemink Belgium
Maxine Taylor United Kingdom
Malin Darnell Sweden
Sylvie Klieber
Citations per year, relative to Sylvie Klieber Sylvie Klieber (= 1×) peers Malin Darnell

Countries citing papers authored by Sylvie Klieber

Since Specialization
Citations

This map shows the geographic impact of Sylvie Klieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Klieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Klieber more than expected).

Fields of papers citing papers by Sylvie Klieber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Klieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Klieber. The network helps show where Sylvie Klieber may publish in the future.

Co-authorship network of co-authors of Sylvie Klieber

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Klieber. A scholar is included among the top collaborators of Sylvie Klieber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Klieber. Sylvie Klieber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jain, Tushar, Bianka Prinz, Alexander Michel, et al.. (2024). Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows. mAbs. 16(1). 2384104–2384104. 4 indexed citations
2.
Teutonico, Donato, et al.. (2023). Prediction of CYP Down Regulation after Tusamitamab Ravtansine Administration (a DM4‐Conjugate), Based on an In Vitro–In Vivo Extrapolation Approach. Clinical Pharmacology & Therapeutics. 115(2). 278–287. 2 indexed citations
3.
4.
5.
Chaloin, Laurent, Patrick Balaguer, Jean‐Marc Pascussi, et al.. (2015). Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling. Toxicological Sciences. 148(1). 261–275. 14 indexed citations
6.
Klieber, Sylvie, et al.. (2015). Evaluation of Normalization Methods To Predict CYP3A4 Induction in Six Fully Characterized Cryopreserved Human Hepatocyte Preparations and HepaRG Cells. Drug Metabolism and Disposition. 44(1). 50–60. 19 indexed citations
7.
Klieber, Sylvie, et al.. (2015). Applicability of second‐generation upcyte® human hepatocytes for use in CYP inhibition and induction studies. Pharmacology Research & Perspectives. 3(5). e00161–e00161. 26 indexed citations
8.
Chapy, Hélène, et al.. (2015). PBPK modeling of irbesartan: incorporation of hepatic uptake. Biopharmaceutics & Drug Disposition. 36(8). 491–506. 14 indexed citations
9.
Pénarier, Géraldine, et al.. (2014). Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device. Xenobiotica. 45(1). 29–44. 53 indexed citations
10.
Gerbal‐Chaloin, Sabine, Sylvie Klieber, Cédric Duret, et al.. (2014). The WNT/β-Catenin Pathway Is a Transcriptional Regulator of CYP2E1, CYP1A2, and Aryl Hydrocarbon Receptor Gene Expression in Primary Human Hepatocytes. Molecular Pharmacology. 86(6). 624–634. 56 indexed citations
11.
12.
Klieber, Sylvie, et al.. (2014). Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug. Pharmacology Research & Perspectives. 2(3). e00044–e00044. 20 indexed citations
13.
Vassal, T, et al.. (2013). Effect of deuteration on the metabolism and clearance of some pharmacologically active compounds—synthesis and in vitro metabolism of deuterated derivatives of dronedadrone. Journal of Labelled Compounds and Radiopharmaceuticals. 56(9-10). 504–512. 12 indexed citations
14.
Vinci, Bruna, Cédric Duret, Sylvie Klieber, et al.. (2011). Modular bioreactor for primary human hepatocyte culture: Medium flow stimulates expression and activity of detoxification genes. Biotechnology Journal. 6(5). 554–564. 89 indexed citations
15.
Klieber, Sylvie, et al.. (2010). The Use of Human Hepatocytes to Investigate Drug Metabolism and CYP Enzyme Induction. Methods in molecular biology. 640. 295–308. 12 indexed citations
16.
Klieber, Sylvie, Viviane Meunier, Olivier Fedeli, et al.. (2009). Contribution of the N‐glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans. The FASEB Journal. 23(S1). 1 indexed citations
17.
Klieber, Sylvie, Viviane Meunier, Olivier Fedeli, et al.. (2008). Contribution of the N-Glucuronidation Pathway to the Overall in Vitro Metabolic Clearance of Midazolam in Humans. Drug Metabolism and Disposition. 36(5). 851–862. 46 indexed citations
18.
Daher, Wassim, Lydie Pélinski, Sylvie Klieber, et al.. (2006). IN VITRO METABOLISM OF FERROQUINE (SSR97193) IN ANIMAL AND HUMAN HEPATIC MODELS AND ANTIMALARIAL ACTIVITY OF MAJOR METABOLITES ON PLASMODIUM FALCIPARUM. Drug Metabolism and Disposition. 34(4). 667–682. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malin Darnell Breakdown of academic impact, for papers by María José Gómez Lechón Breakdown of academic impact, for papers by Kaori Nakamoto Breakdown of academic impact, for papers by Frederic Moulin Breakdown of academic impact, for papers by Chitra Kanchagar Breakdown of academic impact, for papers by Isabel Conde Breakdown of academic impact, for papers by J. E. Dinger Breakdown of academic impact, for papers by Akiko Koeda Breakdown of academic impact, for papers by Janneke Keemink Breakdown of academic impact, for papers by Maxine Taylor
Rankless by CCL
2026